TBX21 and congestive heart failure: It has been known for years that the immune response in patients with CHF is shifted towards the Th1 pathway (9) and in our study we have shown that this response is even more exacerbated in CMV+ patients, possibly as a control to the possible reactivations of the virus, with an increased expression of TBX21 and IFN-γ (51).